There have been a number of astronomical shifts in medicine over the centuries, from the discovery of antibiotics to the development of the first vaccines.
But today, a new shift is happening: A shift away from the one-size-fits-all approach that the field has held to for centuries and towards personalized treatments that are based on an individual’s genes, or in some cases, genetically modified versions of their own cells.
The new approach, interchangeably called personalized or precision medicine, relies on new technologies like gene sequencing and editing, cloud storage and artificial intelligence to tailor treatment plans and medicines for individuals.
A panel of leading experts in the field discussed the newest developments and biggest potentials of personalized medicine at the 2018 GeekWire Summit. Watch the full video of the panel above.
Panelists include Jay Shendure of the University of Washington, Vineti co-founder and chief strategy officer Heidi Hagen and Elizabeth Krakow, a researcher at the Fred Hutchinson Cancer Research Center. Moderated by Corey Schmid, general partner at Seven Peaks Ventures.
